Literature DB >> 15655242

Patients with treatable malignant diseases--including heart failure--are entitled to specialist care.

John G F Cleland1.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15655242      PMCID： PMC543984          DOI： 10.1503/cmaj.045307

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  17 in total

Review 1.  The heart failure epidemic: exactly how big is it?

Authors:  J G Cleland; A Khand; A Clark
Journal:  Eur Heart J       Date:  2001-04       Impact factor: 29.983

2.  How to assess new treatments for the management of heart failure: composite scoring systems to assess the patients' clinical journey.

Authors:  John G F Cleland
Journal:  Eur J Heart Fail       Date:  2002-06       Impact factor: 15.534

Review 3.  Is aspirin "the weakest link" in cardiovascular prophylaxis? The surprising lack of evidence supporting the use of aspirin for cardiovascular disease.

Authors:  John G F Cleland
Journal:  Prog Cardiovasc Dis       Date:  2002 Jan-Feb       Impact factor: 8.194

4.  Is the prognosis of heart failure improving?

Authors:  J G Cleland; I Gemmell; A Khand; A Boddy
Journal:  Eur J Heart Fail       Date:  1999-08       Impact factor: 15.534

5.  Incidence of newly diagnosed heart failure in UK general practice.

Authors:  S Johansson; M A Wallander; A Ruigómez; L A García Rodríguez
Journal:  Eur J Heart Fail       Date:  2001-03       Impact factor: 15.534

6.  Clinical events leading to the progression of heart failure: insights from a national database of hospital discharges.

Authors:  A U Khand; I Gemmell; A C Rankin; J G Cleland
Journal:  Eur Heart J       Date:  2001-01       Impact factor: 29.983

7.  Impact of specialist follow-up in outpatients with congestive heart failure.

Authors:  Justin A Ezekowitz; Carl van Walraven; Finlay A McAlister; Paul W Armstrong; Padma Kaul
Journal:  CMAJ       Date:  2005-01-18       Impact factor: 8.262

Review 8.  A systematic review of telemonitoring for the management of heart failure.

Authors:  Amala A Louis; Tracy Turner; Marcia Gretton; Angela Baksh; John G F Cleland
Journal:  Eur J Heart Fail       Date:  2003-10       Impact factor: 15.534

9.  The EuroHeart Failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis.

Authors:  J G F Cleland; K Swedberg; F Follath; M Komajda; A Cohen-Solal; J C Aguilar; R Dietz; A Gavazzi; R Hobbs; J Korewicki; H C Madeira; V S Moiseyev; I Preda; W H van Gilst; J Widimsky; N Freemantle; Joanne Eastaugh; J Mason
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

Review 10.  The heart failure revascularisation trial (HEART): rationale, design and methodology.

Authors:  J G F Cleland; N Freemantle; S G Ball; R S Bonser; P Camici; S Chattopadhyay; D Dutka; J Eastaugh; J Hampton; S Large; M S Norell; D J Pennell; J Pepper; S Sanda; R Senior; D Smith
Journal:  Eur J Heart Fail       Date:  2003-06       Impact factor: 15.534
View more
  1 in total

Review 1.  Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis.

Authors:  Robyn A Clark; Sally C Inglis; Finlay A McAlister; John G F Cleland; Simon Stewart
Journal:  BMJ       Date:  2007-04-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.